Related Experiment Video
Updated: Aug 13, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells
Abstract:
We have previously shown that a dual system for controlling gene expression that relies both on transcriptional regulation and DNA recombination mediated by the site-directed recombinase, Flp, effectively controls the expression of a gene encoding diphtheria toxin (DT-A). In this study, we investigated the use of a chimeric modified enhancer/promoter sequence of the human prostate-specific antigen (PSA) gene to regulate DT-A expression in human prostate cancer cells in culture, in xenografts derived from these cells, and in autochthonous tumors in TRAMP mice. Following adenoviral delivery of DNA encoding PSA promoter-driven Flp recombinase and DT-A, we demonstrate that this transcriptional/DNA recombination control strategy effectively activates DT-A expression in a manner that correlates with the amount of PSA and androgen in cells. Significantly, the size of xenografts was reduced by 50%, and tumor cells in TRAMP mice died following intratumoral injection of DT-A viruses. Direct injection of virally-delivered DT-A into normal mouse prostates resulted in a dramatic reduction in the size of the gland. Our results suggest that the PSA promoter-driven Flp recombinase regulatory system will allow for targeted death of PSA-expressing cells. When combined with newly developed strategies for targeted gene delivery, this approach holds promise as an effective systemically-administered therapy for metastatic prostate cancer.
Insights
This study developed a dual gene control system using prostate-specific antigen (PSA) promoter regulation and Flp recombinase to target diphtheria toxin (DT-A) expression. This approach effectively reduced prostate tumor size and induced cancer cell death, showing promise for prostate cancer therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Gene expression control is crucial for targeted cancer therapies.
- A dual system combining transcriptional regulation and DNA recombination offers enhanced control.
- The prostate-specific antigen (PSA) promoter is a validated target for prostate cancer therapies.
Purpose of the Study:
- To investigate a novel dual gene expression control system for targeted cancer therapy.
- To evaluate the efficacy of a PSA promoter-driven Flp recombinase system regulating diphtheria toxin (DT-A) expression.
- To assess the therapeutic potential of this system in prostate cancer models.
Main Methods:
- Adenoviral delivery of DNA encoding PSA promoter-driven Flp recombinase and DT-A.
- Utilized human prostate cancer cells in culture, xenografts, and TRAMP mouse models.
- Monitored DT-A expression, tumor size reduction, and cell viability.
Main Results:
- DT-A expression was effectively activated in a manner correlating with PSA and androgen levels.
- Xenograft tumor size was reduced by 50% following treatment.
- Intratumoral injection of DT-A viruses led to significant tumor cell death and prostate size reduction in mice.
Conclusions:
- The PSA promoter-driven Flp recombinase system enables targeted death of PSA-expressing cells.
- This approach holds promise for developing effective systemically-administered therapies for metastatic prostate cancer.
- Further development combined with targeted gene delivery strategies could enhance therapeutic outcomes.
Related Concept Videos
Replicative Cell Senescence
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

